Li Juan, Zheng Yahua, Ma Jingjing, Zhang Yiqing, Dong Hongyi, Chen Lijun, Lu Shunshun, Lu Shi
Department of Nursing, Ningbo Medical Center LiHuili Hospital, Ningbo, China.
Department of Infectious Diseases, Ningbo Medical Center LiHuili Hospital, Ningbo, China.
BMC Infect Dis. 2025 Aug 6;25(1):988. doi: 10.1186/s12879-025-11367-7.
Catheter-related bloodstream infection (CRBSI) is a severe hospital-acquired infection primarily associated with using central venous catheters (CVCs). With the rise of antibiotic resistance and the emergence of multidrug-resistant organisms (MDROs), there is a growing concern about the relationship between MDROs and CRBSI.
To explore the association between MDROs and CRBSI.
A retrospective study was conducted on hospitalized patients with implanted CVCs over 54 months (January 2019 to June 2023).
We included 50,718 patients with indwelling central venous catheters; 122 were diagnosed with central venous CRBSI) The incidence of CRBSI was 0.24% (122/50,718 patients). The rate of MDRO infections among non-CRBSI patients was only 3.86%, while the rate among CRBSI patients was 62.30% (χ² = 1065.80, p < 0.001). After excluding factors related to age, gender, medical history, environmental factors (ward of residence, length of hospitalization), catheter factors (catheter placement site, duration of catheterization, number of insertions), and other factors (duration of fever, abnormal white blood cell counts, frequency of mechanical ventilation) associated with CRBSI infection, the odds ratio for MDROs was 4.63 (95% CI: 2.86-7.50; P < 0.001; Fully adjusted model).
MDROs are independently associated with a higher incidence of CRBSI. These findings highlight the critical need for targeted infection control strategies against MDRO-associated CRBSI and formulate specific management strategies for these infections while promoting interdisciplinary collaboration to improve patient outcomes.
导管相关血流感染(CRBSI)是一种严重的医院获得性感染,主要与使用中心静脉导管(CVC)有关。随着抗生素耐药性的上升和多重耐药菌(MDRO)的出现,人们越来越关注MDRO与CRBSI之间的关系。
探讨MDRO与CRBSI之间的关联。
对54个月(2019年1月至2023年6月)期间植入CVC的住院患者进行回顾性研究。
我们纳入了50718例留置中心静脉导管的患者;122例被诊断为中心静脉CRBSI。CRBSI的发生率为0.24%(122/50718例患者)。非CRBSI患者中MDRO感染率仅为3.86%,而CRBSI患者中该率为62.30%(χ² = 1065.80,p < 0.001)。在排除与CRBSI感染相关的年龄、性别、病史、环境因素(居住病房、住院时间)、导管因素(导管置入部位、置管时间、插入次数)以及其他因素(发热持续时间、白细胞计数异常、机械通气频率)后,MDRO的优势比为4.63(95%CI:2.86 - 7.50;P < 0.001;完全调整模型)。
MDRO与CRBSI的较高发生率独立相关。这些发现凸显了针对MDRO相关CRBSI制定针对性感染控制策略的迫切需求,并为这些感染制定具体管理策略,同时促进跨学科合作以改善患者结局。